41 results on '"D, Aissaoui"'
Search Results
2. CHARACTERISATION AND RATIONALISATION OF URBAN EFFLUENTS IN THE TIZI-OUZOU REGION (ALGERIA)
- Author
-
D. Aissaoui and M. S. Metahri
- Subjects
Urban waste, normalisation, inhabitant equivalent. ,Agriculture (General) ,S1-972 ,Plant culture ,SB1-1110 - Abstract
The knowledge of the composition of urban wastewater discharges is an essential parameter to ensure the relevance of the choice and sizing of appropriate treatment systems to guarantee the quality objectives of the receiving environments. The results obtained allowed us to calculate the daily production per capita of physical, hydrocarbon, nitrogen and phosphorus pollution, specific to the study area. The values of the ratios calculated are : 30.02 g/IE/d for SM, 66.64% less than the reference discharge, i.e., 90 g/IE/d; 33.97 g/IE/d for BOD5, 43.38% less than the reference discharge, i.e., 60 g/IE/d; 53.80 g/IE/d for COD, 55.17% less than the reference discharge, i.e., 120 g/IE/d; 3.14 g/IE/d for TN, 68.28% below the reference value of 9.9 g/IE/d and 1.07 g/IE/d for TP, also 53.50% below the reference value of 2 g/IE/d. These results show that the calculated values reflect a different reality than the reference values. This approach could optimise the choice and sizing of treatment works.
- Published
- 2022
- Full Text
- View/download PDF
3. Performance enhancement of three-stage axial turbine for Clean Organic Rankine Cycle system driven by low-temperature heat source
- Author
-
T.T. Naas, M. Telha, L. Laib, H. Shakhawat, A. Bacha, A. Taibaoui, A.Z. Naas, and D. Aissaoui
- Subjects
Three-stage axial turbine ,Turbine efficiency,Low temperature heat sources ,Cleaning Organic Ranking Cycle ,Renewable energy sources ,TJ807-830 ,Environmental engineering ,TA170-171 - Abstract
High performances of Organic Rankine Cycle (ORC) system are widely used in various industrial applications. Axial flow turbine at low temperature heat source is of major importance in some processes. This work focuses on numerical analyses to improve high efficiency of a small Organic Rankine Cycle (ORC) axial turbine using n-pentane as a working fluid. Different turbine stages are proposed to ensure maximum performance for the Organic Rankine Cycle (ORC) application. In order to characterize the hydrodynamic and thermodynamic performances, 3D RANS computations are suggested for five different rotational speeds(1000 rpm, 2000 rpm, 4000 rpm, 8000 rpm, and 16,000 rpm), and four mass flow rates ranging from 0.2 to 0.5 kg/s with inlet temperature of 365 K.The results indicate that the highest turbine efficiency of 87% in the two-stage turbine with rotational speed 16,000 rpm and inlet mass flow rate 0.2 kg/s, where the mass flow rate 0.5 kg/s gives highest power output value of 10,751W.Theturbine efficiency and power output are 88.03% and 12,950 W in the steady state for three-stage turbine configuration. The transient computational process leads to the maximum values of 88% and 12,932Wforturbine efficiency and power output. These results highlight the potential of using micro-three-stage axial turbine of Organic Rankine Cycle (ORC) systems for the exchange of low temperature heat sources.
- Published
- 2021
- Full Text
- View/download PDF
4. Radiotherapy of ductal carcinoma in situ after conservative surgery: what is the role of the boost?
- Author
-
R. Ben Amor, R. Abidi, D. Aissaoui, M. Bohli, S. Zarraa, A. Yousfi, S. Yahiaoui, A. Belaid, and C. Nasr
- Subjects
Neoplasms. Tumors. Oncology. Including cancer and carcinogens ,RC254-282 - Published
- 2021
- Full Text
- View/download PDF
5. Are clinical and molecular features similar in inflammatory breast cancer and non-inflammatory breast cancer?
- Author
-
D. Aissaoui, M. Bohli, R. Ben Amor, J. Yahyaoui, A. Hamdoun, R. Moujahed, and L. Kochbati
- Subjects
Neoplasms. Tumors. Oncology. Including cancer and carcinogens ,RC254-282 - Published
- 2021
- Full Text
- View/download PDF
6. Tolerance and outcome of hypofractionated whole breast irradiation in young women: from controversies to evidence
- Author
-
M. Bohli, D. Aissaoui, R. Ben Amor, J. Yahyaoui, A. Hamdoun, R. Moujahed, and L. Kochbati
- Subjects
Neoplasms. Tumors. Oncology. Including cancer and carcinogens ,RC254-282 - Published
- 2021
- Full Text
- View/download PDF
7. Impact of irradiation of the internal mammary lymph nodes on heart and lung doses
- Author
-
D. Aissaoui, M. Bohli, R. Ben Amor, J. Yahyaoui, A. Hamdoun, R. Moujahed, and L. Kochbati
- Subjects
Neoplasms. Tumors. Oncology. Including cancer and carcinogens ,RC254-282 - Published
- 2021
- Full Text
- View/download PDF
8. Hypofractionated radiation therapy after radical mastectomy: predictive factors of acute skin toxicity
- Author
-
R. Ben Amor, M. Bohli, F. Noubbigh, D. Aissaoui, J. Yahiaoui, A. Hamdoun, and L. Kochbati
- Subjects
Neoplasms. Tumors. Oncology. Including cancer and carcinogens ,RC254-282 - Published
- 2021
- Full Text
- View/download PDF
9. Performance enhancement of three-stage axial turbine for Clean Organic Rankine Cycle system driven by low-temperature heat source
- Author
-
D. Aissaoui, A.Z. Naas, A. Bacha, T.T. Naas, M. Telha, A. Taibaoui, L. Laib, and H. Shakhawat
- Subjects
Organic Rankine cycle ,Work (thermodynamics) ,Mass flow ,Nuclear engineering ,TJ807-830 ,Environmental engineering ,Rotational speed ,Building and Construction ,TA170-171 ,Turbine efficiency,Low temperature heat sources ,Turbine ,Three-stage axial turbine ,Renewable energy sources ,Axial compressor ,Mass flow rate ,Environmental science ,Working fluid ,Electrical and Electronic Engineering ,Cleaning Organic Ranking Cycle - Abstract
High performances of Organic Rankine Cycle (ORC) system are widely used in various industrial applications. Axial flow turbine at low temperature heat source is of major importance in some processes. This work focuses on numerical analyses to improve high efficiency of a small Organic Rankine Cycle (ORC) axial turbine using n-pentane as a working fluid. Different turbine stages are proposed to ensure maximum performance for the Organic Rankine Cycle (ORC) application. In order to characterize the hydrodynamic and thermodynamic performances, 3D RANS computations are suggested for five different rotational speeds(1000 rpm, 2000 rpm, 4000 rpm, 8000 rpm, and 16,000 rpm), and four mass flow rates ranging from 0.2 to 0.5 kg/s with inlet temperature of 365 K.The results indicate that the highest turbine efficiency of 87% in the two-stage turbine with rotational speed 16,000 rpm and inlet mass flow rate 0.2 kg/s, where the mass flow rate 0.5 kg/s gives highest power output value of 10,751W.Theturbine efficiency and power output are 88.03% and 12,950 W in the steady state for three-stage turbine configuration. The transient computational process leads to the maximum values of 88% and 12,932Wforturbine efficiency and power output. These results highlight the potential of using micro-three-stage axial turbine of Organic Rankine Cycle (ORC) systems for the exchange of low temperature heat sources.
- Published
- 2021
10. Hypofractionated radiation therapy after radical mastectomy: predictive factors of acute skin toxicity
- Author
-
Lotfi Kochbati, F. Noubbigh, M. Bohli, R. Ben Amor, J. Yahiaoui, D. Aissaoui, and A. Hamdoun
- Subjects
medicine.medical_specialty ,Hypofractionated Radiation Therapy ,Skin toxicity ,business.industry ,medicine.medical_treatment ,Medicine ,Surgery ,General Medicine ,Radiology ,business ,lcsh:Neoplasms. Tumors. Oncology. Including cancer and carcinogens ,lcsh:RC254-282 ,Radical mastectomy - Published
- 2021
11. PO-1955 OAR dose constraints consensus in hypofractionated breast cancer radiotherapy is urgently needed!
- Author
-
M. Bohli, J. Yahiaoui, D. Aissaoui, A. Hamdoun, Lotfi Kochbati, and R. Ben Amor
- Subjects
Oncology ,medicine.medical_specialty ,business.industry ,Internal medicine ,Medicine ,Radiology, Nuclear Medicine and imaging ,Hematology ,business ,Breast cancer radiotherapy ,Dose constraints - Published
- 2021
- Full Text
- View/download PDF
12. PO-1120 skin toxicity of hypofractionated vs conventional irradiation after mastectomy for breast cancer
- Author
-
M. el bessi, A. Hamdoun, J. Yahyaoui, N. nsiri, R. Ben Amor, Lotfi Kochbati, D. Aissaoui, and M. Bohli
- Subjects
Oncology ,medicine.medical_specialty ,business.industry ,medicine.medical_treatment ,Hematology ,medicine.disease ,Breast cancer ,Skin toxicity ,Internal medicine ,medicine ,Radiology, Nuclear Medicine and imaging ,Irradiation ,business ,Mastectomy - Published
- 2021
- Full Text
- View/download PDF
13. Radiotherapy of ductal carcinoma in situ after conservative surgery: what is the role of the boost?
- Author
-
D. Aissaoui, M. Bohli, S. yahiaoui, R. Abidi, S. zarraa, R. Ben Amor, A. Belaid, A. Yousfi, and C. Nasr
- Subjects
Radiation therapy ,In situ ,medicine.medical_specialty ,business.industry ,medicine.medical_treatment ,medicine ,Surgery ,General Medicine ,Ductal carcinoma ,lcsh:Neoplasms. Tumors. Oncology. Including cancer and carcinogens ,business ,lcsh:RC254-282 - Published
- 2021
- Full Text
- View/download PDF
14. PO-1517 Which impact of the COVID-19 pandemic on residents training in radiotherapy?
- Author
-
W. Siala, Wafa Mnejja, D. Aissaoui, F. Dhouib, Nejla Fourati, and J. Daoud
- Subjects
2019-20 coronavirus outbreak ,medicine.medical_specialty ,Oncology ,Coronavirus disease 2019 (COVID-19) ,business.industry ,Digital Poster: Other ,Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) ,Pandemic ,Emergency medicine ,medicine ,Radiology, Nuclear Medicine and imaging ,Hematology ,business - Published
- 2021
15. PO-1473 Impact of lock down related to COVID 19 pandemic on travel cost to radiotherapy department
- Author
-
A. Hamdoun, M. Bohli, J. Yahyaoui, Lotfi Kochbati, D. Aissaoui, and R. Ben Amor
- Subjects
2019-20 coronavirus outbreak ,Record locking ,Coronavirus disease 2019 (COVID-19) ,business.industry ,Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) ,Radiotherapy department ,Digital Poster: Health services research/health economics ,Travel cost ,Hematology ,medicine.disease ,Oncology ,Pandemic ,Medicine ,Radiology, Nuclear Medicine and imaging ,Medical emergency ,business - Published
- 2021
16. PO-1981 Dosimetric predectifs factors of acute skin toxicity after hypofractionated breast irradiation
- Author
-
A. Hamdoun, J. Yahyaoui, D. Aissaoui, R. Ben Amor, M. Bohli, and Lotfi Kochbati
- Subjects
Skin toxicity ,Oncology ,business.industry ,Medicine ,Radiology, Nuclear Medicine and imaging ,Hematology ,Irradiation ,Nuclear medicine ,business - Published
- 2021
- Full Text
- View/download PDF
17. PO-1418: Left breast radiotherapy: what is the dose received by the left ventricle ?
- Author
-
D. Aissaoui, C. Nasr, R. Abidi, and K. Mahjoubi
- Subjects
Radiation therapy ,medicine.medical_specialty ,Left breast ,medicine.anatomical_structure ,Oncology ,Ventricle ,business.industry ,medicine.medical_treatment ,medicine ,Radiology, Nuclear Medicine and imaging ,Hematology ,Radiology ,business - Published
- 2020
- Full Text
- View/download PDF
18. Inflammatory Breast Cancer: Clinical Characteristics and Influence of Molecular Subtypes on Treatment Response
- Author
-
M. Bohli, D. Aissaoui, J. Yahyaoui, A. Hamdoun, Lotfi Kochbati, R. Moujahed, and R. Ben Amor
- Subjects
Oncology ,Cancer Research ,medicine.medical_specialty ,Poor prognosis ,Treatment response ,business.industry ,General Medicine ,medicine.disease ,Inflammatory breast cancer ,Breast cancer ,Internal medicine ,Medicine ,skin and connective tissue diseases ,business - Abstract
Introduction: Inflammatory Breast Cancer (IBC) is a rare and very aggressive breast cancer with poor prognosis. The prevalence is different from a country to another. In Tunisia, it is about 5 to 7% of breast cancer. The aim of this study is to describe the epidemiological and histopathological features of patients with inflammatory breast cancer and to evaluate the treatment response according to the molecular subtypes. Methods: This retrospective review identified 31 patients with no metastatic IBC treated in our radiotherapy department between December 2019 and November 2020. IBC was confirmed using the clinical criteria. Baseline clinic-pathological and treatment information was retrieved from medical records. Statistical analysis was performed with IBM SPSS V.20. Results: Median age was 51.3 years [27-68]. 48% of tumors were grade 3. The average tumor size was 36mm [10-90]. The histological type was ductal carcinoma in 97%. Vascular invasion was noted in 24 patients (77%). Thirty patients were classified as stage IIIB and one patient was IIIC. 74% were hormone receptor positive and 45% were HER2 positive. Luminal B was the predominant subtype (52%) followed by Her2 positive (32%), Luminal A (23%), and triple negative (3%) All patients had chemotherapy: neoadjuvant for 26 patients (84%) and adjuvant for 5 patients (16%). Nine patients (29%) had tumor pathological complete response (pCR). Partial response was observed in 18 patients (58%). Lymph node pCR was noted in 16% of cases (n=5). Endocrine therapy and trastuzumab were given to 76% and 45% of patients, respectively. The influence of the molecular subtype was not statistically significant on the response to neoadjuvant treatment. The highest rate of pCR were 43% for Her2positive, then 27%, 21% and 9% for Luminal B, Luminal A and Triple negative, respectively (p=0.2). Conclusion: Our study showed a high percentage of hormone receptor and Her2+ (74% and 45% respectively) in IBC. Luminal B was the most frequent subtype. Anthracycline-based chemotherapy and trastuzumab improved the pCR rate: 44% for Her2positive. Triple negative showed poorer pCR than other breast cancer subtype without a significant difference. A larger study is warranted to confirm our findings.
- Published
- 2021
- Full Text
- View/download PDF
19. 85P Hypofrationated radiotherapy for breast cancer: Does obesity increase the skin toxicity?
- Author
-
R. Ben Amor, J. Yahiaoui, A. Hamdoun, D. Aissaoui, M. Bohli, and Lotfi Kochbati
- Subjects
Oncology ,medicine.medical_specialty ,business.industry ,medicine.medical_treatment ,Hematology ,medicine.disease ,Obesity ,Radiation therapy ,Skin toxicity ,Breast cancer ,Internal medicine ,medicine ,business - Published
- 2021
- Full Text
- View/download PDF
20. Are clinical and molecular features similar in inflammatory breast cancer and non-inflammatory breast cancer?
- Author
-
R. Moujahed, J. Yahyaoui, R. Ben Amor, M. Bohli, Lotfi Kochbati, D. Aissaoui, and A. Hamdoun
- Subjects
Oncology ,medicine.medical_specialty ,business.industry ,Internal medicine ,medicine ,Surgery ,General Medicine ,lcsh:Neoplasms. Tumors. Oncology. Including cancer and carcinogens ,medicine.disease ,business ,lcsh:RC254-282 ,Inflammatory breast cancer - Published
- 2021
- Full Text
- View/download PDF
21. Quand et comment proposer la radiothérapie thoracique palliative pour les cancers pulmonaires en fin de vie ?
- Author
-
M. Bohli, R. Moujahed, Lotfi Kochbati, R. Ben Amor, D. Aissaoui, A. Hamdoune, and J. Yahyaoui
- Subjects
Pulmonary and Respiratory Medicine - Abstract
Introduction La radiotherapie (RT) thoracique palliative joue un role important dans la prise en charge des cancers pulmonaires. Elle permet une amelioration des symptomes dans 50–80 % des cas. Toutefois, les effets de la RT ne sont pas immediats. L’objectif de notre etude etait d’identifier les facteurs associes a une survie courte, moins de 4 semaines suivant la RT thoracique palliative. Methodes Etude retrospective menee entre 2018 et 2020 incluant 50 patients traites par RT thoracique pulmonaire palliative pour un cancer du poumon dans le service de RT de l’hopital Abderrahman Mami, Tunis. Deux groupes de patients ont ete identifies et compares : les patients ayant une survie courte moins de 4 semaines et ceux ayants une survie plus de 4 semaines. L’âge moyen etait de 62 ans (43–86). Le performance status (PS) etait 1 dans 42 % (21 cas) et 2–3 dans 58 % des cas (29 patients). Le type histologique etait le carcinome non a petite cellule dans 88 % (44 patients). La tumeur etait classee stade III et IV respectivement dans 38 % (19 patients) et 62 % des cas (31 patients). La chimiotherapie etait administree dans 84 % des cas (n = 42). La RT etait delivree a la dose de 20 Gy en 5 fractions (n = 25), 30 Gy en 10 fractions (n = 17) 8 Gy en 1 fraction (n = 2). L’analyse statistique etait pratiquee en utilisant le SPSS version 21. L’âge, le PS, le type histologique, le stade, l’etat respiratoire, le traitement systemique, le fractionnement de la RT ont ete correle a la survie en utilisant le test Chi2. Resultats La survie mediane etait de 4 mois. Le taux de survie globale a 4 semaines et 12 semaines etaient respectivement de 88 % et 72 %. Vingt pour cent des patients (10 cas) avaient une survie ≤ 4 semaines et 80 % (40 cas) avaient une survie > 4 semaines. La RT etait delivree durant les 4 dernieres semaines de vie en une fraction dans 50 % des cas et en multi-fractions dans 15 % des cas (p = 0,04). Une survie courte etait significativement associee a un PS2-3, 31 % contre 5 % en cas de PS a 1 (p = 0,02). La survie etait courte chez 45 % des patients ayants une dyspnee de repos conte 13 % en son absence (p = 0,03) L’âge, le type histologique, le stade et la chimiotherapie anterieure n’etaient pas correles a une survie courte. Conclusion Notre etude a montre que le PS 2-3 et/ou la dyspnee de repos etaient associes a une survie courte (≤ 4 semaines) apres une RT thoracique palliative. Ces facteurs pronostiques devraient etre pris en compte avant de proposer l’indication d’une RT thoracique dont l’effet est generalement differe.
- Published
- 2021
- Full Text
- View/download PDF
22. PO-0831: IMRT for recurrent nasopharyngeal cancer: OAR tolerance and acute toxicity
- Author
-
R. Abidi, C. Nasr, K. Mahjoubi, A. Essadok, and D. Aissaoui
- Subjects
Oncology ,medicine.medical_specialty ,Recurrent nasopharyngeal cancer ,business.industry ,Internal medicine ,medicine ,Radiology, Nuclear Medicine and imaging ,Hematology ,business ,Acute toxicity - Published
- 2020
- Full Text
- View/download PDF
23. Poster abstracts of the 18th Pan Arab Cancer Congress. TUNISIA. April 19-21, 2018
- Author
-
J, Aarab, Ibtissem, Abbess, Fathi, Abdalla, Z, Abdelaziz, S, Abdelfattah, I, Abdelli, K, Abdelmajid, Zied, Abdelsselem, N, Abdelwahed, Nihed, Abdessayed, Bassem, Abid, K, Abid, R, Abidi, Asma, Abudabbous, Sana, Abujanah, Afaf, Aburwais, E, Acacha, Nessrine, Acharfi, Nejmeddine, Affes, R, Aftis, I, Ahalli, Mr, Aid, D, Aissaoui, A, Alaoui, M, Alaoui, Salaheddin, Albatran, Aldehmani, Mamdouh, Rabia, Alkikkli, A, Allam, S, Aloulou, Omar, Alqawi, Mussa A, Alragig, Ali, Alsharksi, K Oualla L, Amaadour, L, Amaadour, N, Ameziane, A, Ammari, H, Ammour, R, Amrane, N, Annad, E, Aouati, S, Aouichat, S, Aouragh, S, Arifi, Md, Astra, M, Atassi, Nidhal, Ati, K, Atoui, L, Atreche, S, Ayachi, I, Ayadi, Mohammed Ali, Ayadi, Mouna, Ayadi, Jihene, Ayari, Haroun, Ayed, K, Ayed, Henda, Ayedi, Ines, Ayedi, M, Azegrar, Heifa, Azzouz, Fathi, Babdalla, R, Bachiri, Z, Bachiri, M, Baghdad, R, Bahloul, A, Bahouli, M, Bahri, I, Baississ, Hanae, Bakkali, Mehdi, Balti, O, Baraket, Hayfa, Bargaoui, Rim, Batti, Ahlem, Bedioui, R, Begag, Z, Behourah, Imtinene, Belaid, Asma, Belaïd, Amine, Ben Abdallah, Ichrak, Ben Abdallah, Slim, Ben Ahmed, Tarek, Ben Ahmed, M, Ben Azaiz, M A, Ben Chehida, Leila, Ben Fatma, D, Ben Ghachem, T, Ben Ghachem, J, Ben Hassouna, S, Ben Hmida, Sonia, Ben Nasr, Dalel, Ben Nejima, K, Ben Rahal, M, Ben Rejeb, S, Ben Rhouma, I, Ben Safta, A, Ben Salem, Yosr, Ben Zargouna, Ichrak, Benabdallah, H, Benabdella, Mohamed Zied, Benabdessalem, Khaled, Benahmed, Slim, Benahmed, Hazem, Benameur, S, Benasr, Fz, Benbrahim, W, Benbrahim, Z, Benbrahim, Ma, Benchehida, Yasser, Bencheikh, Tarek, Bendhiab, Leila, Benfatma, A, Bengueddach, M, Benhami, Jamel, Benhassouna, W, Benhbib, Noureddine, Benjaafar, R, Benkali, Wala, Benkridis, A, Benlaloui, Mahmoud, Benmaitig, A, Benmansour, M, Benmouhoub, Farouk, Benna, H, Benna, Marouan, Benna, Mehdi, Benna, H, Bennabdellah, Khaled, Benrahal, Ines, Bensafta, Hanène, Bensalah, A, Bensalem, Mohammed, Bensaud, Riadh, Benslama, M, Benyoub, K, Benzid, H, Bergaoui, M, Beroual, S, Berrad, Y, Berrazaga, Z, Bezzaz, Hanene, Bhiri, M, Bibi, Mohamed Yassine, Binous, Ahlem, Blel, Jamela M, Boder, N, Bouaouina, Hanen, Bouaziz, S, Bouchoucha, Tahia, Boudawara, Zaher, Boudawara, A, Bouderbala, Rima, Bouhali, Malek, Bouhani, R, Boujarnija, Salah, Boujelben, Nadia, Boujelbene, I, Boukerzaza, H, Boukhari, W, Boulfoul, R, Boulma, N, Boumansour, A, Bouned, A, Bounedjar, I, Bouraoui, Saadia, Bouraoui, Rym, Bourigua, M, Bourmech, Hamza, Bousaffa, A, Bousahba, C, Bousrih, A, Boussarsar, Hammouda, Boussen, Selwa, Boutayeb, Khaled, Bouzaidi, Faten, Bouzaiene, H, Bouzaiene, Z, Bouzerzour, Kamel, Bouzid, N, Bouzid, Dw, Bouzidi, W, Bouzidi, Abderrazek, Bouzouita, S, Brahimi, A, Brahmia, Abdelbaset, Buhmeida, Kais, Chaaben, Hatem, Chaabouni, Mohamed, Chaabouni, Kais, Chaabène, H, Chaari, Ines, Chaari, M, Chaari, Imene, Chabchoub, K, Chabeene, K, Chaker, Marouene, Chakroun, M, Charfi, Slim, Charfi, R, Chargui, Md, Charles, Mohamed, Chebil, Khadidja, Cheikchouk, Beya, Chelly, Ines, Chelly, N, Cheraiet, Aziz, Cherif, Mohamed, Cherif, A, Cherifi, T, Chikhrouhou, A, Chikouche, A, Chirouf, Nesrine, Chraiet, Y, Collan, Zhanglin, Cui, Habiba, Dabbebi, Amira, Daldoul, I, Damouche, H, Daoud, N, Daoud, J, Daoued, Khadija, Darif, Dalia O, Darwish, Z, Derbouz, Amine, Derouiche, T T, Dhibe, Tarek, Dhibet, A, Djallaoui, N, Djami, K, Djebbes, H, Djedi, S, Djeghim, L, Djellali, A, Djellaoui, K, Djilat, R, Djouabi, H, Doumbia, Mustafa, Drah, M, Dridi, Mohamed, Hsairi, S, Elabbassi, Fz, Elallia, Zohra, Elati, M, Elattassi, Houda, Elbenna, Mohamed A, Elfagieh, Omran, Elfaitori, Hebatallah, Elfannas, Amine, Elghali, Mohamed Amine, Elghali, Salah, Elgonti, O Elamine, Elhadj, R, Elhazzaz, H, Elkacemi, Khaoula, Elkinany, Youssri, Elkissi, F, Elloumi, Olfa, Elmaalel, I S, Elmajjaou, S, Elmajjaoui, H, Elmhabrech, Fz, Elmrabet, Wesam A, Elsaghayer, Adam, Elzagheid, Fatma, Emaetig, H, Erraichi, Mejda, Essid, Nada, Ewshah, Faten, Ezzairi, Raja, Faleh, Sourour, Fallah, Amr Lotfy, Farag, L, Farhat, R, Fehri, Jihène, Feki, Sami, Fendri, Sana, Fendri, Z, Fessi, Taha, Filali, A, Fissah, M, Fourati, N, Fourati, Mounir, Frikha, C S, Fuchs, Azza, Gabssi, F, Gachi, Selma, Gadria, A, Gammoudi, I, Ganzoui, Asma, Gargoura, Imen, Ghaddabb, Imen, Gharbi, Maroua, Gharbi, E, Ghazouani, N, Gheriani, Abdelmonom, Ghorbel, L, Ghorbel, A, Ghozi, Rafik, Ghrissi, Amine, Gouader, A, Goucha, A, Guebsi, I, Guellil, Fatma, Guermazi, Sondess, Guesmi, Wafa, Guetari, N, Habak, A, Haddad, S, Haddad, Abderrazek, Haddaoui, I, Hadef, Abdelbasit Faraj, Hader, A, Hadiji, F, Hadjarab, Myriam, Hadoussa, Nadia, Hadoussa, Ch, Hafsa, Mariem, Hafsia, Ahmed, Hajji, M, Hajmansour, S, Hamdi, Z, Hamici, S, Hamida, Fehmi, Hamila, Selim, Hamissa, Boussen, Hammouda, Slim, Haouet, I, Harhira, Ayed, Haroun, K, Hassouni, A, Hdiji, Monia, Hechiche, L, Hejjane, C, Hellal, Manseurs, Henni, K, Herbegue, L, Hichami, M, Hikem, Alaa, Hmad, Lina, Hmida, S, Hmissa, Makrem, Hochlaf, A, Houas, M, Houhani, Ali, Huwidi, Chau, Ian, B N, Ibrahim, Noha Y, Ibrahim, H, Idir, Dhilel, Issaoui, A, Itaimi, A E, Izem, Olfa, Jaidane, Daoud, Jamel, H, Jamous, Medsalah, Jarrar, Mohamed Salah, Jarrar, Saber, Jarray, M, Jebsi, Hafedh, Jmal, Abdallah, Juwid, Ons, Kaabia, A, Kablouti, Imene, Kacem, K, Kacem, M Y, Kaid, M, Kallel, R, Kallel, H, Kammoun, Syrjänen, Kari, Sarra, Karrit, Hela, Kchir, Nidhameddine, Kchir, T, Kebdani, N, Kechad, H, Kehili, E, Kerboua, Hassib, Keskes, Nora N, Kessi, N, Khababa, H, Khaldi, Afef, Khanfir, B, Khater, A, Khelif, S, Khemiri, K, Khennouf, H, Khouni, S, Khrouf, Zahra, Kmira, L, Kochbati, Asma, Korbi, N, Kouadri, F, Kouhen, M, Krarti, M, Handoussa, Yanzhi, Hsu, Ons, Laakom, Matti, Laato, Soumaya, Labidi, Fz, Lahlali, A, Lahmidi, A, Lalaoui, Naija, Lamia, A, Lamri, Feryel, Letaief, M R, Letaief, M, Aldehmani, A, Rafael, A M, Liepa, Faten, Limaiem, K, Limam, H, Loughlimi, F, Ltaief, Nadia, Maamouri, Mohamed, Mabrouk, R, Madouri, N, Mahjoub, Z, Mahjoubi, M, Mahrsi, Hochlef, Makrem, W, Mallek, Moez, Manitta, L, Mansoura, Houyem, Mansouri, Maher, Maoua, W, Maoui, Chakroun, Marouene, K, Marzouk, S, Masmoudi, Fatma, May, I, Meddeb, Khedija, Meddeb, S, Meddour, Fatma, Medhioub, Nesrine, Mejri, Mohamed Rochdi, Melizi, N, Mellas, Rihab, Melliti, A, Melzi, N, Merair, F Z, Merrouki, C, Mersali, O, Messalbi, Lina, Messaoudi, S, Messioud, K, Messoudi, Sarra, Mestiri, Amal, Mezlini, Amel, Mezlini, F, Mghirbi, H, Mhabrech, A, Mhiri, N, Midoun, Rabia, Milud, B, Missaoui, Aymen, Mnasser, Wafa, Mnejja, Moncef, Mokni, Amina, Mokrani, Mokrani, Mokrani, R, Moujahed, Y, Moukasse, A, Mouzount, Karima, Mrad, Mohamed Hedi, Mraidha, Nejib, Mrizak, Rafik, Mzali, Y, Mzid, F, M'ghirbi, Abdelwaheb, Nakhli, Chiraz, Nasr, Salsabil, Nasri, Gef, Noubigh, Daoud, Nouha, L, Nouia, Y, Nouira, A, Noureddine, O, Nouri, Atsushi, Ohtsu, H, Ouahbi, K, Oualla, Y, Ouanes, H, Ouaz, A, Ouikene, N, Ouldbessi, Iqbal, Parker, S, Pyrhonen, H, Rachdi, K, Rahal, Khaled, Rahal, M, Rahoui, Henda, Raies, Soumaya, Rameh, K, Reguieg, Haitham, Rejab, R, Rejiba, Mohamed Salah, Rhim, S, Riahi, N, Rouimel, N, Saad Saoud, K, Saadi, Myriam, Saadi, A, Sadou, Ines, Saguem, T, Sahnoun, H, Sahnoune, Saida, Sakhri, A, Sallemi, Asma, Sassi, W, Sbika, C, Sedkaoui, S, Sefiane, A, Sellami, Pyrhönen, Seppo, H, Sfaoua, Syrine, Sghaier, Ali, Shagan, W, Siala, I, Slim, M, Slimene, S, Soltani, S, Souilah, Marwa, Souissi, Badreddine, Sriha Badreddine, Youssef, Swaisi, A, Taibi, T, Taktak, Ghofran, Talbi, S W, Talha, Soha M, Talima, S, Tbessi, N, Tebani, S, Tebra, S, Tebramrad, D, Telaijia, A, Tenni, Ahmedou, Tolba, Yassen, Topov, K, Touil, Nabil, Toumi, W, Toumi, N, Tounsi, Aymen, Trigui, R, Trigui, W, Triki, Maroua, Walha, Ines, Werda, Haythem, Yacoub, Yosra, Yahyaoui, A, Yaich, R, Yaici, M, Yamouni, I, Yeddes, D, Yekrou, Ma, Yousfi, N, Yousfi, M A, Youssfi, L, Zaabar, Sonia, Zaied, I, Zaim, Walid, Zakhama, S, Zayed, Alia, Zehani, I, Zemni, Yosr, Zenzri, S, Zeraoula, O, Zouiten, Olfa, Zoukar, Ws, Zrafi, Aref, Zribi, and Naji, Zubia
- Published
- 2018
24. Médulloblastomes chez l’adulte : profil épidémioclinique et particularités thérapeutiques et pronostiques
- Author
-
A. Boussarsar, R. Abidi, D. Aissaoui, Lotfi Kochbati, and Chiraz Nasr
- Subjects
Oncology ,Radiology, Nuclear Medicine and imaging - Abstract
Objectif de l’etude Decrire les aspects epidemiocliniques et therapeutiques du medulloblastome de l’adulte et analyser son aspect evolutif en fonction des facteurs pronostiques. Materiel et methode Nous avons realise une etude retrospective sur 55 patients adultes irradies dans le service de radiotherapie de l’institut Salah–Azaiz sur une periode de 18 ans(1994–2012). Resultats L’âge median etait de 28 ans [18 ans–54 ans]. Le sex-ratio (hommes/femmes) etait de 1,6. Le delai moyen de diagnostic etait de 3 mois. Le syndrome d’hypertension intracrânienne etait le motif de consultation de tous les patients. La localisation etait hemispherique cerebelleuse dans 47 % des cas. La taille moyenne etait de 4 cm. La chirurgie etait totale ou subtotale dans 73 % des cas. Le medulloblastome etait de type classique dans 60 % des cas et de type desmoplasique dans 40 %. Quarante-huit patients ont recu une radiotherapie adjuvante a visee curative, dans un delai moyen de 83 jours. La chimiotherapie, associant l’ etoposide et la carboplatine, n’etait faite que chez les patients metastatiques (n = 4). La survie globale etait de 53 % a 5 ans et de 34 % a 10 ans. La dose cerebrospinale etait un facteur pronostique de survie globale. La probabilite de survie sans recidive etait de 64 % a 5 ans et 41 % a 10 ans . Le delai moyen de rechute etait de 4,3 ans. La rechute etait locale dans 60 % des cas. La dose cerebrospinale ainsi que l’envahissement du plancher du quatrieme ventricule etaient des facteurs pronostiques de survie sans recidive. Le residu postoperatoire n’etait pas un facteur pronostique de survie globale ni de survie sans recidive. Conclusion Nos resultats, compares a ceux de la litterature, nous confortent dans l’idee que la reduction de la dose dans l’axe cerebrospinal (
- Published
- 2018
- Full Text
- View/download PDF
25. P01 scorpion toxin, a potential therapeutic agent against glioblastoma
- Author
-
Najet Srairi-Abid, R. Ben Aissa, D. Aissaoui, C. Vandier, A. Chantome, Saoussen Mlayah-Bellalouna, M. El Ayeb, and T. Chagour
- Subjects
Scorpion toxin ,business.industry ,medicine ,Cancer research ,Toxicology ,medicine.disease ,business ,Glioblastoma - Published
- 2016
- Full Text
- View/download PDF
26. Synthesis, physicochemical and pharmacological characterizations of a tetra-[methylimidazolium] dihydrogen decavanadate, inhibiting the IGR39 human melanoma cells development.
- Author
-
Aissa T, Aissaoui-Zid D, Moslah W, Khamessi O, Ksiksi R, Oltermann M, Ruck M, Zid MF, and Srairi-Abid N
- Subjects
- Humans, Cell Line, Tumor, Apoptosis drug effects, Vanadates chemistry, Vanadates pharmacology, Vanadates chemical synthesis, Melanoma drug therapy, Melanoma pathology, Melanoma metabolism, Imidazoles chemistry, Imidazoles pharmacology, Imidazoles chemical synthesis, Antineoplastic Agents pharmacology, Antineoplastic Agents chemical synthesis, Antineoplastic Agents chemistry
- Abstract
Melanoma is a skin cancer that arises from melanocytes and can spread quickly to the other organs of the body, if not treated early. Generally, melanoma shows an inherent resistance to conventional therapies. In this regard, new potential drugs are being developed as possible treatments for melanoma. In this paper, we report the synthesis of a new decavanadate compound with organic molecules for a potential therapeutic application. The tetra-[methylimidazolium] dihydrogen decavanadate(V) salt (C
4 H7 N2 )4 [H2 V10 O28 ] is characterized by single-crystal X-ray diffraction, by FT-IR, UV-Vis and51 V NMR spectroscopy, as well as by thermal analysis (TGA and DSC). The compound crystallizes in the monoclinic centrosymmetric space group P21 /c. Its formula unit consists of one dihydrogen decavanadate anion [H2 V10 O28 ]4- and four organic 4-methylimidazolium cations (C4 H7 N2 )+ . Important intermolecular interactions are N-H···O and O-H···O hydrogen bonds and π-π stacking interactions between the organic cations, revealed by analysis of the Hirshfeld surface and its two-dimensional fingerprint plots. Interestingly, this compound inhibits the viability of IGR39 cells with IC50 values of 14.65 μM and 4 μM after 24 h and 72 h of treatment, respectively. The analysis of its effect by flow cytometry using an Annexin V-FITC/IP cell labeling, showed that (C4 H7 N2 )4 H2 V10 O28 compound induced IGR39 cell apoptosis and necrosis. Molecular docking studies performed against TNFR1 and GPR40, as putative targets, suggest that the (C4 H7 N2 )4 [H2 V10 O28 ] compound may act as inhibitor of these proteins, known to be overexpressed in melanoma cells. Therefore, we could consider it as a new potential metallodrug against melanoma., Competing Interests: Declaration of competing interest The authors declare no conflicts of interest., (Copyright © 2024. Published by Elsevier Inc.)- Published
- 2024
- Full Text
- View/download PDF
27. Survival and prognostic factors in adult medulloblastoma: the Salah Azaiz Institute experience.
- Author
-
Abidi R, Boussarsar A, Yahyaoui S, Aissaoui D, Mousli A, Kochbati L, Belaid A, and Nasr C
- Subjects
- Child, Adult, Humans, Combined Modality Therapy, Prognosis, Retrospective Studies, Disease-Free Survival, Survival Rate, Medulloblastoma drug therapy, Medulloblastoma pathology, Cerebellar Neoplasms surgery, Cerebellar Neoplasms pathology
- Abstract
Background: Medulloblastoma is the most common malignant brain tumor in children. This entity in adulthood is rare. The aim of our study is to evaluate therapeutic results and prognostic factors of adult medulloblastoma treated at our institute with post-operative radiotherapy., Methods: We retrospectively reviewed a cohort of 55 patients with medulloblastoma who underwent radiation in the department of radiation oncology of institute Salah Azaiz (Tunis) over a 18-year period (1994-2012)., Results: The surgery was total or subtotal resection in 73% of cases. Forty-eight patients received radiotherapy to the entire craniospinal axis as part of the curative treatment. The median interval from surgery to the initiation of radiotherapy was 83 days. Etoposide-cisplatin chemotherapy was only performed in metastatic patients ( n = 4). The 5-years and 10-years overall survival rates were respectively 53 and 34%. The dose of radiotherapy to the craniospinal axis was a prognostic factor. The 5-years and 10-years event-free-survival rates were 64 and 41%. Reduction in the dose of radiotherapy to the craniospinal axis and fourth ventricular floor involvement were correlated with a worse event-free survival., Conclusion: Our results, compared to those of the literature, conclude that the reduction in the dose of radiotherapy to the craniospinal axis (<34 Gy) in the standard risk group of adult medulloblastoma could not be done without chemotherapy. In the high-risk group of adult medulloblastoma, radiotherapy to the cerebrospinal axis at the dose of 36 Gy with chemotherapy, is required for disease control.
- Published
- 2024
- Full Text
- View/download PDF
28. Effect of Gamma Irradiation on Pathogenic Staphylococcus aureus in Packaged Ready-to-Eat Salads Treated with Biological Extracts.
- Author
-
Zernadji W, Jebri S, Rahmani F, Amri I, Aissaoui D, Trabelsi MH, Yahya M, Amri I, and Hmaied F
- Subjects
- Humans, Staphylococcus aureus, Salads, Oils, Volatile pharmacology, Oils, Volatile chemistry
- Abstract
Providing pathogen-free ready-to-eat (RTE) salads is critical for all consumers, especially individuals with weakened immunity. In this study, the efficacy of γ-irradiation on Staphylococcus aureus (S. aureus) in freshly packaged salads (4.24 log CFU/g) treated with essential oil (EO) and myrtle juice during 10 days of storage and their impact on organoleptic properties were investigated. EO was extracted by hydrodistillation and the chemical composition was analyzed by gas chromatography with Flame Ionization Detector (GC/FID) and gas chromatography/mass spectrometry (GC/MS). Myrtle juice was prepared from fresh fruits. The cytotoxic effects of Thymus capitatus (T. capitatus) EO against a normal human umbilical vein endothelial cell (HUVEC) were assessed. GC/FID and GC-MS analysis of the thyme EO revealed the presence of 13 compounds, including carvacrol (79.55%) and p-cymene (7.93%) as major components. The EO was found to be noncytotoxic, with concentrations lower than 0.16 µL/mL. A reduction of more than 3 log CFU/g and a total inactivation of S. aureus were achieved with the combination of gamma irradiation at 0.5 kGy with myrtle juice at 6 µL/mL and EO at 0.08 µL/mL, respectively. The treatment of fresh RTE salads with thyme and myrtle juice was evaluated as acceptable by the sensory panel. The combined effect showed a synergistic potential on the inactivation of S. aureus., Competing Interests: Declaration of competing interest The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper., (Copyright © 2024 The Author(s). Published by Elsevier Inc. All rights reserved.)
- Published
- 2024
- Full Text
- View/download PDF
29. Insights into the mechanisms governing P01 scorpion toxin effect against U87 glioblastoma cells oncogenesis.
- Author
-
Mlayah-Bellalouna S, Aissaoui-Zid D, Chantome A, Jebali J, Souid S, Ayedi E, Mejdoub H, Belghazi M, Marrakchi N, Essafi-Benkhadir K, Vandier C, and Srairi-Abid N
- Abstract
The emerging concept of small conductance Ca
2+ -activated potassium channels (SKCa ) as pharmacological target for cancer treatment has significantly increased in recent years. In this study, we isolated the P01 toxin from Androctonus australis (Aa) scorpion venom and investigated its effect on biological properties of glioblastoma U87, breast MDA-MB231 and colon adenocarcinoma LS174 cancer cell lines. Our results showed that P01 was active only on U87 glioblastoma cells. It inhibited their proliferation, adhesion and migration with IC50 values in the micromolar range. We have also shown that P01 reduced the amplitude of the currents recorded in HEK293 cells expressing SK2 channels with an IC50 value of 3 pM, while it had no effect on those expressing SK3 channels. The investigation of the SKCa channels expression pattern showed that SK2 transcripts were expressed differently in the three cancer cell lines. Particularly, we highlighted the presence of SK2 isoforms in U87 cells, which could explain and rely on the specific activity of P01 on this cell line. These experimental data highlighted the usefulness of scorpion peptides to decipher the role of SKCa channels in the tumorigenesis process, and develop potential therapeutic molecules targeting glioblastoma with high selectivity., Competing Interests: The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest., (Copyright © 2023 Mlayah-Bellalouna, Aissaoui-Zid, Chantome, Jebali, Souid, Ayedi, Mejdoub, Belghazi, Marrakchi, Essafi-Benkhadir, Vandier and Srairi-Abid.)- Published
- 2023
- Full Text
- View/download PDF
30. Hypofractionated radiotherapy after breast-conserving surgery: Clinical and dosimetric factors predictive of acute skin toxicity.
- Author
-
Ben Amor R, Bohli M, Naimi Z, Aissaoui D, Mejri N, Yahyaoui J, Hamdoun A, and Kochbati L
- Subjects
- Humans, Female, Retrospective Studies, Neoplasm Staging, Breast pathology, Radiotherapy, Adjuvant adverse effects, Radiotherapy, Adjuvant methods, Mastectomy, Segmental, Breast Neoplasms radiotherapy, Breast Neoplasms surgery, Breast Neoplasms pathology
- Abstract
Purpose: The purpose of this study was to evaluate acute skin toxicity in early breast cancer patients treated with hypofractionated radiotherapy (HFRT) after breast-conserving surgery and to identify factors predictive for grade ≥ 2 acute skin toxicity., Materials and Methods: A monocentric retrospective study was carried out using cases treated between December 2017 and November 2020. We analyzed data from 202 patients with early breast cancer treated with 3D hypofractionated RT (40.05 Gy in 15 fractions) to the whole breast with or without regional lymph nodes, followed by 13.35 Gy in 5 fractions to the tumor bed. Acute skin toxicity was monitored during RT according to CTCAE (common toxicity criteria for adverse events) scale. Univariate and multivariate analyses were performed to assess predictive factors of acute skin toxicity., Results: Overall, there was no erythema in 9%, grade 1 erythema in 64.5%, grade 2 in 24%, and grade 3 in 2.5%. No grade 4 erythema was seen. Median delay between RT initiating and maximum skin reaction was 22 days (range 4-44 days). No patient interrupted treatment. In univariate analysis, the rate of acute skin toxicity grade 2---3 (G2-3) was significantly higher for patients with larger tumor size (p = 0.02), body mass index > 27 (p = 0.04), and time between chemotherapy (CT) and RT less than 20 days (p = 0.01). Dosimetric risk factors for acute skin toxicity G2‑3 were breast volume > 800 cc (p = 0.000), boost volume > 18 cc (p = 0.002), V105% > 40 cc (p = 0.03), and Dmax > 56 Gy (p = 0.007). CT, trastuzumab, regional lymph node radiation, and age were not correlated with increased skin toxicity. In multivariate analysis, acute skin toxicity correlated with T stage (p = 0.032), breast volume > 800 cc (p = 0.012), boost volume > 18 cc (p = 0.04), and Dmax > 56 Gy (p = 0.035)., Conclusion: Our results confirm that whole breast with or without lymph nodes hypofractionated RT is safe and well tolerated. The factors strongly associated with a decreased risk of G2‑3 skin toxicity are T1, breast volume < 800 c, boost volume < 18 cc, and Dmax < 56 Gy. Long-term follow-up is needed to evaluate late toxicity., (© 2022. The Author(s), under exclusive licence to Springer-Verlag GmbH Germany.)
- Published
- 2023
- Full Text
- View/download PDF
31. Multipurpose E-bioplatform targeting Kv channels in whole cancer cells and evaluating of their potential therapeutics.
- Author
-
Zouari M, Aissaoui-Zid D, Campuzano S, Barderas R, Srairi-Abid N, Pingarrón JM, and Raouafi N
- Subjects
- Carbon, Horseradish Peroxidase, Humans, Ion Channels, Peptides, Potassium Channel Blockers pharmacology, Potassium Channel Blockers therapeutic use, Potassium Channels, Immunoconjugates, Neoplasms drug therapy, Scorpion Venoms pharmacology
- Abstract
Potassium ion channels are expressed on the cell membranes, implicated in wide variety of cell functions and intimately linked to cancer cell behaviors. This work reports the first bioplatform described to date allowing simple and rapid detection of ion channel activity and the effect of their inhibitors in cancer cells. The methodology involves interrogation of the channel of interest from cells specifically captured on magnetic immunoconjugates using specific detection antibodies that are labeled with horseradish peroxidase enzyme. The channel activity is reflected by an amperometric signal transduction of the resulting magnetic bioconjugates onto screen-printed carbon electrodes. The bioplatform feasibility was proven for the detection of the Kv channels in U87 human glioblastoma cells and their blocking by scorpion venom KAaH1 and KAaH2 peptides. The obtained results confirm the high sensitivity (detection of 5 U87 cells⋅mL
-1 and 0.06 μg mL-1 of KAaH2) of the proposed bioplatform and their versatility to detect both potassium channel activity and their potential inhibitors, in a given cancer cell line, with high sensitivity in a simple and fast way. This bioplatform presents potential applications in cancer and theranostic of channelopathies., Competing Interests: Declaration of competing interest The authors declare the following financial interests/personal relationships which may be considered as potential competing interests: Noureddine Raouafi reports financial support was provided by Tunisian Ministry of Higher Education and Scientific Research., (Copyright © 2022 Elsevier B.V. All rights reserved.)- Published
- 2022
- Full Text
- View/download PDF
32. MARCKS as a Potential Therapeutic Target in Inflammatory Breast Cancer.
- Author
-
Manai M, ELBini-Dhouib I, Finetti P, Bichiou H, Reduzzi C, Aissaoui D, Ben-Hamida N, Agavnian E, Srairi-Abid N, Lopez M, Amri F, Guizani-Tabbane L, Rahal K, Mrad K, Manai M, Birnbaum D, Mamessier E, Cristofanilli M, Boussen H, Kharrat M, Doghri R, and Bertucci F
- Subjects
- Humans, Phosphatidylinositol 3-Kinases, Proto-Oncogene Proteins c-akt, Retrospective Studies, Tensins, Biological Products therapeutic use, Inflammatory Breast Neoplasms drug therapy, Inflammatory Breast Neoplasms pathology, Myristoylated Alanine-Rich C Kinase Substrate
- Abstract
Inflammatory breast cancer (IBC) is the most pro-metastatic form of breast cancer (BC). We previously demonstrated that protein overexpression of Myristoylated Alanine-Rich C Kinase Substrate (MARCKS) protein was associated with shorter survival in IBC patients. MARCKS has been associated with the PI3K/AKT pathway. MARCKS inhibitors are in development. Our objective was to investigate MARCKS, expressed preferentially in IBC that non-IBC (nIBC), as a novel potential therapeutic target for IBC. The biologic activity of MPS, a MARCKS peptide inhibitor, on cell proliferation, migration, invasion, and mammosphere formation was evaluated in IBC (SUM149 and SUM190) and nIBC (MDA-MB-231 and MCF7) cell lines, as well as its effects on protein expression in the PTEN/AKT and MAPK pathways. The prognostic relevance of MARCKS and phosphatase and tensin homolog (PTEN) protein expression as a surrogate marker of metastasis-free survival (MFS) was evaluated by immunohistochemistry (IHC) in a retrospective series of archival tumor samples derived from 180 IBC patients and 355 nIBC patients. In vitro MPS impaired cell proliferation, migration and invasion, and mammosphere formation in IBC cells. MARCKS inhibition upregulated PTEN and downregulated pAKT and pMAPK expression in IBC cells, but not in nIBC cells. By IHC, MARCKS expression and PTEN expression were negatively correlated in IBC samples and were associated with shorter MFS and longer MFS, respectively, in multivariate analysis. The combination of MARCKS-/PTEN+ protein status was associated with longer MFS in IBC patient only ( p = 8.7 × 10
-3 ), and mirrored the molecular profile (MARCKS-downregulated/PTEN-upregulated) of MPS-treated IBC cell lines. In conclusion, our results uncover a functional role of MARCKS implicated in IBC aggressiveness. Associated with the good-prognosis value of the MARCKS-/PTEN+ protein status that mirrors the molecular profile of MPS-treated IBC cell lines, our results suggest that MARCKS could be a potential therapeutic target in patients with MARCKS-positive IBC. Future preclinical studies using a larger panel of IBC cell lines, animal models and analysis of a larger series of clinical samples are warranted in order to validate our results.- Published
- 2022
- Full Text
- View/download PDF
33. Psychological Responses and Strategies Towards the COVID-19 Pandemic Among Higher Education Students in Portugal and Switzerland: A Mixed-Methods Study.
- Author
-
Schwander-Maire F, Querido A, Cara-Nova T, Dixe MA, Aissaoui D, Charepe Z, Christie D, and Laranjeira C
- Abstract
Background: The COVID-19 pandemic has caused overwhelming changes in individual and community daily-life, resulting from the public health measures implemented to contain it, and also from its psychological and socio-economic consequences. These shifts and consequences impacted the entire population, but some groups are more likely to be affected by these changes, including higher education students., Objectives: a) to investigate mental health status and its determinants among higher-education students in Portugal and Switzerland; and b) to explore adjustment patterns used by these students to overcome the impact of the COVID-19 pandemic., Methods: A cross-sectional study with a mixed-methods sequential explanatory design was conducted in two phases. First, an online survey was conducted among higher education students in Portugal and Switzerland, in Portuguese and French respectively. A convenience sampling method was used. Second, some participants from the first phase were invited to participate in four online focus group discussions (two in each country) using a maximum variation sampling method., Results: The survey was answered by 1,880 students. Portuguese students revealed higher levels of stress and anxiety, but lower depression symptoms and less resilient coping compared to Swiss respondents. Hope was identified as an explanatory variable for mental health symptoms in students from both countries. In the focus groups ( n = 27), 13 adjustment strategies were found, which were subdivided into three spheres: personal, social, and contextual., Conclusions: The results suggest that the COVID-19 pandemic had a mild to moderate impact on most of the evaluated mental health variables. Nevertheless, the students reacted and mobilized positive short-term strategies, which need to be reinforced in order to prevent long-term psychological harm. In addition, our results can inform psychosocial interventions to minimize psychological impact, anxiety, depression, and stress due to sanitary crises or other population-wide problems or disasters., Competing Interests: The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest., (Copyright © 2022 Schwander-Maire, Querido, Cara-Nova, Dixe, Aissaoui, Charepe, Christie and Laranjeira.)
- Published
- 2022
- Full Text
- View/download PDF
34. Strengthening Anti-Glioblastoma Effect by Multi-Branched Dendrimers Design of a Scorpion Venom Tetrapeptide.
- Author
-
Moslah W, Aissaoui-Zid D, Aboudou S, Abdelkafi-Koubaa Z, Potier-Cartereau M, Lemettre A, ELBini-Dhouib I, Marrakchi N, Gigmes D, Vandier C, Luis J, Mabrouk K, and Srairi-Abid N
- Subjects
- Animals, Antineoplastic Agents chemistry, Cell Line, Tumor, Cell Proliferation drug effects, Dendrimers chemistry, Dendrimers pharmacology, Humans, Oligopeptides chemistry, Scorpion Venoms chemistry, Scorpions, Antineoplastic Agents pharmacology, Central Nervous System Neoplasms drug therapy, Glioblastoma drug therapy, Oligopeptides pharmacology, Scorpion Venoms pharmacology
- Abstract
Glioblastoma is the most aggressive and invasive form of central nervous system tumors due to the complexity of the intracellular mechanisms and molecular alterations involved in its progression. Unfortunately, current therapies are unable to stop its neoplastic development. In this context, we previously identified and characterized AaTs-1, a tetrapeptide (IWKS) from Androctonus autralis scorpion venom, which displayed an anti-proliferative effect against U87 cells with an IC
50 value of 0.57 mM. This peptide affects the MAPK pathway, enhancing the expression of p53 and altering the cytosolic calcium concentration balance, likely via FPRL-1 receptor modulation. In this work, we designed and synthesized new dendrimers multi-branched molecules based on the sequence of AaTs-1 and showed that the di-branched (AaTs-1-2B), tetra-branched (AaTs-1-4B) and octo-branched (AaTs-1-8B) dendrimers displayed 10- to 25-fold higher effects on the proliferation of U87 cells than AaTs-1. We also found that the effects of the newly designed molecules are mediated by the enhancement of the ERK1/2 and AKT phosphorylated forms and by the increase in p53 expression. Unlike AaTs-1, AaTs-1-8B and especially AaTs-1-4B affected the migration of the U87 cells. Thus, the multi-branched peptide synthesis strategy allowed us to make molecules more active than the linear peptide against the proliferation of U87 glioblastoma cells.- Published
- 2022
- Full Text
- View/download PDF
35. AaTs-1: A Tetrapeptide from Androctonus australis Scorpion Venom, Inhibiting U87 Glioblastoma Cells Proliferation by p53 and FPRL-1 Up-Regulations.
- Author
-
Aissaoui-Zid D, Saada MC, Moslah W, Potier-Cartereau M, Lemettre A, Othman H, Gaysinski M, Abdelkafi-Koubaa Z, Souid S, Marrakchi N, Vandier C, Essafi-Benkhadir K, and Srairi-Abid N
- Subjects
- Animals, Antineoplastic Agents chemistry, Humans, Oligopeptides chemistry, Scorpions, Antineoplastic Agents pharmacology, Cell Proliferation drug effects, Gene Expression Regulation, Neoplastic drug effects, Glioblastoma drug therapy, Glioblastoma metabolism, Oligopeptides pharmacology, Receptors, Formyl Peptide biosynthesis, Receptors, Lipoxin biosynthesis, Scorpion Venoms chemistry, Tumor Suppressor Protein p53 biosynthesis, Up-Regulation drug effects
- Abstract
Glioblastoma is an aggressive cancer, against which medical professionals are still quite helpless, due to its resistance to current treatments. Scorpion toxins have been proposed as a promising alternative for the development of effective targeted glioblastoma therapy and diagnostic. However, the exploitation of the long peptides could present disadvantages. In this work, we identified and synthetized AaTs-1, the first tetrapeptide from Androctonus australis scorpion venom (Aa), which exhibited an antiproliferative effect specifically against human glioblastoma cells. Both the native and synthetic AaTs-1 were endowed with the same inhibiting effect on the proliferation of U87 cells with an IC
50 of 0.56 mM. Interestingly, AaTs-1 was about two times more active than the anti-glioblastoma conventional chemotherapeutic drug, temozolomide (TMZ), and enhanced its efficacy on U87 cells. AaTs-1 showed a significant similarity with the synthetic peptide WKYMVm, an agonist of a G-coupled formyl-peptide receptor, FPRL-1, known to be involved in the proliferation of glioma cells. Interestingly, the tetrapeptide triggered the dephosphorylation of ERK, p38, and JNK kinases. It also enhanced the expression of p53 and FPRL-1, likely leading to the inhibition of the store operated calcium entry. Overall, our work uncovered AaTs-1 as a first natural potential FPRL-1 antagonist, which could be proposed as a promising target to develop new generation of innovative molecules used alone or in combination with TMZ to improve glioblastoma treatment response. Its chemical synthesis in non-limiting quantity represents a valuable advantage to design and develop low-cost active analogues to treat glioblastoma cancer.- Published
- 2021
- Full Text
- View/download PDF
36. Psychological Impacts of the COVID-19 Pandemic Among Portuguese and Swiss Higher-Education Students: Protocol for a Mixed Methods Study.
- Author
-
Querido A, Aissaoui D, Dixe MDA, Schwander-Maire F, Cara-Nova T, Charepe Z, and Laranjeira C
- Abstract
Background: Higher-education students are particularly vulnerable to both everyday stressors and mental health problems. Public health emergencies may generate a range of unforeseen potential stressors for vulnerable individuals and communities. The current pandemic has apparently led to an increase in psychiatric symptoms among these students., Objective: The goal of this study is to characterize the psychological impact of the COVID-19 pandemic among Portuguese and Swiss higher-education students., Methods: This project will use a mixed methods sequential explanatory design in Portugal and Switzerland, with two consecutive phases. During Phase I, a quantitative study will assess the psychological responses of higher-education students during the COVID-19 pandemic. A convenience sampling method will be used for collecting information from students. The association between variables will be determined with univariable and multivariable analyses. During Phase II, qualitative data will be collected in order to understand the determinants of psychological stress and the strategies adopted by students as a result of the COVID-19 pandemic, as well as to identify their opinions and feelings about the teaching-learning process during quarantine. In this phase, participants will be selected using a maximum-variation sampling method. Data from focus group discussions will be coded and inductively analyzed using a thematic analysis approach. Finally, quantitative and qualitative results will be merged during interpretation to provide complementary perspectives., Results: This paper describes and discusses the protocol for this mixed methods study, which will be completed in December 2021. This study was formally approved by the local ethics committee (CE/IPLEIRIA/22/2020) in Portugal and authorized by the Swiss Association of Research Ethics Committees, swissethics (CER-VD-2020-02889)., Conclusions: This research can contribute to the development of teaching tools and methods that reinforce positive mental health strategies, hope, and adaptive coping among students, and to the development of a class on mental health interventions in the context of catastrophic and traumatic events. This project will also help government stakeholders as well as health and education professionals safeguard the psychological well-being of students facing an expanding COVID-19 pandemic., International Registered Report Identifier (irrid): PRR1-10.2196/28757., (©Ana Querido, Djamel Aissaoui, Maria Dos Anjos Dixe, Françoise Schwander-Maire, Tanya Cara-Nova, Zaida Charepe, Carlos Laranjeira. Originally published in JMIR Research Protocols (https://www.researchprotocols.org), 29.06.2021.)
- Published
- 2021
- Full Text
- View/download PDF
37. Lebecetin, a snake venom C-type lectin protein, modulates LPS-induced inflammatory cytokine production in human THP-1-derived macrophages.
- Author
-
Jebali J, Zakraoui O, Aissaoui D, Abdelkafi-Koubaa Z, Srairi-Abid N, Marrakchi N, and Essafi-Benkhadir K
- Subjects
- Animals, Humans, Interleukin-10 metabolism, Lectins, C-Type, Lipopolysaccharides, NF-kappa B metabolism, Snake Venoms, Viperidae, Cytokines metabolism, Viper Venoms pharmacology
- Abstract
The excessive production of inflammatory mediators results in an overactive immune response leading to the worsening of various human diseases. Thus, there is a still need to identify molecules able to regulate the inflammatory response. Lebecetin, a C-type lectin protein isolated from Macrovipera lebetina snake venom, was previously characterized as a platelet aggregation inhibitor and antitumor active biomolecule. In the present work, we investigated its effect on the production of some cytokines linked to inflammatory response and the underlying mechanisms in lipopolysaccharide (LPS)-induced THP1 macrophages. Interestingly, we found that lebecetin reduced the levels of the pro-inflammatory cytokines TNF-α, IL-6, and IL-8 while it partially increased LPS-induced secretion of the immunomodulatory cytokine IL-10. Furthermore, this modulatory effect was accompanied by decreased activation of ERK1/2, p38, AKT kinases and NF-κB along with reduced expression of αvβ3 integrin. Thus, this study highlights the promising role of lebecetin as a natural biomolecule that could manage the inflammatory response involved in the development and progression of inflammatory diseases., (Copyright © 2020 Elsevier Ltd. All rights reserved.)
- Published
- 2020
- Full Text
- View/download PDF
38. Trabectedin (Yondelis®) as a Therapeutic Option in Gynecological Cancers: A Focus on its Mechanisms of Action, Clinical Activity and Genomic Predictors of Drug Response.
- Author
-
Souid S, Aissaoui D, Srairi-Abid N, and Essafi-Benkhadir K
- Subjects
- BRCA1 Protein genetics, BRCA2 Protein genetics, Biomarkers, Pharmacological, Female, Genomics, Humans, Antineoplastic Agents, Alkylating pharmacology, Antineoplastic Agents, Alkylating therapeutic use, Breast Neoplasms drug therapy, Genital Neoplasms, Female drug therapy, Trabectedin pharmacology, Trabectedin therapeutic use
- Abstract
The use of predictive biomarkers provides potential individualized cancer therapeutic options to prevent therapy failure as well as serious toxicities. Several recent studies showed that predictive and prognostic biomarkers are a notable personalized strategy to improve patients' care in several cancers. Trabectedin (Yondelis®) is a cytotoxic agent, derived from a marine organism, harbouring a significant antitumor activity against several cancers such as soft tissue sarcoma, ovarian, and breast cancers. Recently and with the advent of molecular genetic testing, BRCA mutational status was found as an important predictor of response to this anticancer drug, especially in gynecological cancers. The aim of this updated review is to discuss the mechanisms of action of trabectedin against the wellknown cancer hallmarks described until today. The current advances were also examined related to genomic biomarkers that can be used in the future to predict the efficacy of this potent anticancer natural molecule in various gynecological cancers., (Copyright© Bentham Science Publishers; For any queries, please email at epub@benthamscience.net.)
- Published
- 2020
- Full Text
- View/download PDF
39. Anti-tumoral effect of scorpion peptides: Emerging new cellular targets and signaling pathways.
- Author
-
Srairi-Abid N, Othman H, Aissaoui D, and BenAissa R
- Subjects
- Animals, Apoptosis, Arthropod Proteins metabolism, Arthropod Venoms metabolism, Cell Proliferation drug effects, Humans, Ion Channels metabolism, Peptides metabolism, Receptors, Growth Factor metabolism, Signal Transduction, Arthropod Proteins therapeutic use, Arthropod Venoms therapeutic use, Channelopathies therapy, Neoplasms therapy, Peptides therapeutic use, Scorpions metabolism
- Abstract
Scorpion toxins have been the subject of many studies exploring their pharmacological potential. The high affinity and the overall selectivity to various types of ionic channels endowed scorpion toxins with a potential therapeutic effect against many channelopathies. These are diseases in which ionic channels play an important role in their development. Cancer is considered as a channelopathy since overexpression of some ionic channels was highlighted in many tumor cells and was linked to the pathology progression. Interestingly, an increasing number of studies have shown that scorpion venoms and toxins can decrease cancer growth in vitro and in vivo. Furthermore through their ability to penetrate the cell plasma membrane, certain scorpion toxins are able to enhance the efficiency of some clinical chemotherapies. These observations back-up the applicability of scorpion toxins as potential cancer therapeutics. In this review, we focused on the anti-cancer activity of scorpion toxins and their effect on the multiple hallmarks of cancer. We also shed light on effectors and receptors involved in signaling pathways in response to scorpion toxins effect. Until now, the anticancer mechanisms described for scorpion peptides consist on targeting ion channels to (i) inhibit cell proliferation and metastasis; and (ii) induce cell cycle arrest and/or apoptosis through membrane depolarization leading to hemostasis deregulation and caspase activation. Putative targets such as metalloproteinases, integrins and/or growth factor receptors, beside ion channels, have been unveiled to be affected by scorpion peptides., (Copyright © 2019. Published by Elsevier Ltd.)
- Published
- 2019
- Full Text
- View/download PDF
40. Functional role of Kv1.1 and Kv1.3 channels in the neoplastic progression steps of three cancer cell lines, elucidated by scorpion peptides.
- Author
-
Aissaoui D, Mlayah-Bellalouna S, Jebali J, Abdelkafi-Koubaa Z, Souid S, Moslah W, Othman H, Luis J, ElAyeb M, Marrakchi N, Essafi-Benkhadir K, and Srairi-Abid N
- Subjects
- Amino Acid Sequence genetics, Animals, Carcinogenesis drug effects, Cell Line, Tumor, Cell Proliferation drug effects, Gene Expression Regulation, Neoplastic drug effects, Humans, Neoplasms drug therapy, Neoplasms genetics, Peptides chemistry, Peptides pharmacology, Potassium metabolism, Potassium Channel Blockers chemistry, Scorpion Venoms chemistry, Scorpions chemistry, Kv1.3 Potassium Channel genetics, Potassium Channel Blockers pharmacology, Scorpion Venoms pharmacology, Shaker Superfamily of Potassium Channels genetics
- Abstract
Voltage-gated potassium (Kv) channels are known to play a pivotal role in the progression of various cancer types and considered as new targets for designing anti-cancer therapy. However, the fact that many Kv channels are expressed in different cell lines makes it difficult to ascribe a functional role for a given Kv channel on a specific aspect of the tumorogenesis. In this work, we showed that although both Kv1.1 and Kv1.3 channels are expressed in U87 (glioblastoma), MDA-MB-231 (breast cancer) and LS174 (colon adenocarcinoma) cells, these respond differently to KAaH1 or KAaH2, two homologous Kv1 blockers from scorpion venom. KAaH1 is active on Kv1.1 and Kv1.3 and was found to inhibit migration and adhesion of U87 cells whereas KAaH2 which is slightly active only on Kv1.1 channel, inhibits their proliferation via the EGFR signaling pathway. The correlation between the electro-physiological activity of the scorpion peptides and their anti-migratory effects suggests the involvement of the Kv1.1 and Kv1.3 channels in the mobility of the three cancer cell lines. Our results showed that besides they can elucidate the implication of Kv1.1 and Kv1.3 channels in molecular mechanisms of neoplastic progression, KAaH1 and KAaH2 may be used as therapeutic tools against glioblastoma., (Copyright © 2018 Elsevier B.V. All rights reserved.)
- Published
- 2018
- Full Text
- View/download PDF
41. Poster abstracts of the 18th Pan Arab Cancer Congress. TUNISIA. April 19-21, 2018.
- Author
-
Aarab J, Abbess I, Abdalla F, Abdelaziz Z, Abdelfattah S, Abdelli I, Abdelmajid K, Abdelsselem Z, Abdelwahed N, Abdessayed N, Abid B, Abid K, Abidi R, Abudabbous A, Abujanah S, Aburwais A, Acacha E, Acharfi N, Affes N, Aftis R, Ahalli I, Aid M, Aissaoui D, Alaoui A, Alaoui M, Albatran S, Mamdouh A, Alkikkli R, Allam A, Aloulou S, Alqawi O, Alragig MA, Alsharksi A, Amaadour KOL, Amaadour L, Ameziane N, Ammari A, Ammour H, Amrane R, Annad N, Aouati E, Aouichat S, Aouragh S, Arifi S, Astra M, Atassi M, Ati N, Atoui K, Atreche L, Ayachi S, Ayadi I, Ayadi MA, Ayadi M, Ayari J, Ayed H, Ayed K, Ayedi H, Ayedi I, Azegrar M, Azzouz H, Babdalla F, Bachiri R, Bachiri Z, Baghdad M, Bahloul R, Bahouli A, Bahri M, Baississ I, Bakkali H, Balti M, Baraket O, Bargaoui H, Batti R, Bedioui A, Begag R, Behourah Z, Belaid I, Belaïd A, Ben Abdallah A, Ben Abdallah I, Ben Ahmed S, Ben Ahmed T, Ben Azaiz M, Ben Chehida MA, Ben Fatma L, Ben Ghachem D, Ben Ghachem T, Ben Hassouna J, Ben Hmida S, Ben Nasr S, Ben Nejima D, Ben Rahal K, Ben Rejeb M, Ben Rhouma S, Ben Safta I, Ben Salem A, Ben Zargouna Y, Benabdallah I, Benabdella H, Benabdessalem MZ, Benahmed K, Benahmed S, Benameur H, Benasr S, Benbrahim F, Benbrahim W, Benbrahim Z, Benchehida M, Bencheikh Y, Bendhiab T, Benfatma L, Bengueddach A, Benhami M, Benhassouna J, Benhbib W, Benjaafar N, Benkali R, Benkridis W, Benlaloui A, Benmaitig M, Benmansour A, Benmouhoub M, Benna F, Benna H, Benna M, Benna M, Bennabdellah H, Benrahal K, Bensafta I, Bensalah H, Bensalem A, Bensaud M, Benslama R, Benyoub M, Benzid K, Bergaoui H, Beroual M, Berrad S, Berrazaga Y, Bezzaz Z, Bhiri H, Bibi M, Binous MY, Blel A, Boder JM, Bouaouina N, Bouaziz H, Bouchoucha S, Boudawara T, Boudawara Z, Bouderbala A, Bouhali R, Bouhani M, Boujarnija R, Boujelben S, Boujelbene N, Boukerzaza I, Boukhari H, Boulfoul W, Boulma R, Boumansour N, Bouned A, Bounedjar A, Bouraoui I, Bouraoui S, Bourigua R, Bourmech M, Bousaffa H, Bousahba A, Bousrih C, Boussarsar A, Boussen H, Boutayeb S, Bouzaidi K, Bouzaiene F, Bouzaiene H, Bouzerzour Z, Bouzid K, Bouzid N, Bouzidi D, Bouzidi W, Bouzouita A, Brahimi S, Brahmia A, Buhmeida A, Chaaben K, Chaabouni H, Chaabouni M, Chaabène K, Chaari H, Chaari I, Chaari M, Chabchoub I, Chabeene K, Chaker K, Chakroun M, Charfi M, Charfi S, Chargui R, Charles M, Chebil M, Cheikchouk K, Chelly B, Chelly I, Cheraiet N, Cherif A, Cherif M, Cherifi A, Chikhrouhou T, Chikouche A, Chirouf A, Chraiet N, Collan Y, Cui Z, Dabbebi H, Daldoul A, Damouche I, Daoud H, Daoud N, Daoued J, Darif K, Darwish DO, Derbouz Z, Derouiche A, Dhibe TT, Dhibet T, Djallaoui A, Djami N, Djebbes K, Djedi H, Djeghim S, Djellali L, Djellaoui A, Djilat K, Djouabi R, Doumbia H, Drah M, Dridi M, Hsairi M, Elabbassi S, Elallia F, Elati Z, Elattassi M, Elbenna H, Elfagieh MA, Elfaitori O, Elfannas H, Elghali A, Elghali MA, Elgonti S, Elhadj OE, Elhazzaz R, Elkacemi H, Elkinany K, Elkissi Y, Elloumi F, Elmaalel O, Elmajjaou IS, Elmajjaoui S, Elmhabrech H, Elmrabet F, Elsaghayer WA, Elzagheid A, Emaetig F, Erraichi H, Essid M, Ewshah N, Ezzairi F, Faleh R, Fallah S, Farag AL, Farhat L, Fehri R, Feki J, Fendri S, Fendri S, Fessi Z, Filali T, Fissah A, Fourati M, Fourati N, Frikha M, Fuchs CS, Gabssi A, Gachi F, Gadria S, Gammoudi A, Ganzoui I, Gargoura A, Ghaddabb I, Gharbi I, Gharbi M, Ghazouani E, Gheriani N, Ghorbel A, Ghorbel L, Ghozi A, Ghrissi R, Gouader A, Goucha A, Guebsi A, Guellil I, Guermazi F, Guesmi S, Guetari W, Habak N, Haddad A, Haddad S, Haddaoui A, Hadef I, Hader AF, Hadiji A, Hadjarab F, Hadoussa M, Hadoussa N, Hafsa C, Hafsia M, Hajji A, Hajmansour M, Hamdi S, Hamici Z, Hamida S, Hamila F, Hamissa S, Hammouda B, Haouet S, Harhira I, Haroun A, Hassouni K, Hdiji A, Hechiche M, Hejjane L, Hellal C, Henni M, Herbegue K, Hichami L, Hikem M, Hmad A, Hmida L, Hmissa S, Hochlaf M, Houas A, Houhani M, Huwidi A, Ian C, Ibrahim BN, Ibrahim NY, Idir H, Issaoui D, Itaimi A, Izem AE, Jaidane O, Jamel D, Jamous H, Jarrar M, Jarrar MS, Jarray S, Jebsi M, Jmal H, Juwid A, Kaabia O, Kablouti A, Kacem I, Kacem K, Kaid MY, Kallel M, Kallel R, Kammoun H, Kari S, Karrit S, Kchir H, Kchir N, Kebdani T, Kechad N, Kehili H, Kerboua E, Keskes H, Kessi NN, Khababa N, Khaldi H, Khanfir A, Khater B, Khelif A, Khemiri S, Khennouf K, Khouni H, Khrouf S, Kmira Z, Kochbati L, Korbi A, Kouadri N, Kouhen F, Krarti M, Handoussa M, Hsu Y, Laakom O, Laato M, Labidi S, Lahlali F, Lahmidi A, Lalaoui A, Lamia N, Lamri A, Letaief F, Letaief MR, Aldehmani M, Rafael A, Liepa AM, Limaiem F, Limam K, Loughlimi H, Ltaief F, Maamouri N, Mabrouk M, Madouri R, Mahjoub N, Mahjoubi Z, Mahrsi M, Makrem H, Mallek W, Manitta M, Mansoura L, Mansouri H, Maoua M, Maoui W, Marouene C, Marzouk K, Masmoudi S, May F, Meddeb I, Meddeb K, Meddour S, Medhioub F, Mejri N, Melizi MR, Mellas N, Melliti R, Melzi A, Merair N, Merrouki FZ, Mersali C, Messalbi O, Messaoudi L, Messioud S, Messoudi K, Mestiri S, Mezlini A, Mezlini A, Mghirbi F, Mhabrech H, Mhiri A, Midoun N, Milud R, Missaoui B, Mnasser A, Mnejja W, Mokni M, Mokrani A, Mokrani M, Moujahed R, Moukasse Y, Mouzount A, Mrad K, Mraidha MH, Mrizak N, Mzali R, Mzid Y, M'ghirbi F, Nakhli A, Nasr C, Nasri S, Noubigh G, Nouha D, Nouia L, Nouira Y, Noureddine A, Nouri O, Ohtsu A, Ouahbi H, Oualla K, Ouanes Y, Ouaz H, Ouikene A, Ouldbessi N, Parker I, Pyrhonen S, Rachdi H, Rahal K, Rahal K, Rahoui M, Raies H, Rameh S, Reguieg K, Rejab H, Rejiba R, Rhim MS, Riahi S, Rouimel N, Saad Saoud N, Saadi K, Saadi M, Sadou A, Saguem I, Sahnoun T, Sahnoune H, Sakhri S, Sallemi A, Sassi A, Sbika W, Sedkaoui C, Sefiane S, Sellami A, Seppo P, Sfaoua H, Sghaier S, Shagan A, Siala W, Slim I, Slimene M, Soltani S, Souilah S, Souissi M, Sriha Badreddine B, Swaisi Y, Taibi A, Taktak T, Talbi G, Talha SW, Talima SM, Tbessi S, Tebani N, Tebra S, Tebramrad S, Telaijia D, Tenni A, Tolba A, Topov Y, Touil K, Toumi N, Toumi W, Tounsi N, Trigui A, Trigui R, Triki W, Walha M, Werda I, Yacoub H, Yahyaoui Y, Yaich A, Yaici R, Yamouni M, Yeddes I, Yekrou D, Yousfi M, Yousfi N, Youssfi MA, Zaabar L, Zaied S, Zaim I, Zakhama W, Zayed S, Zehani A, Zemni I, Zenzri Y, Zeraoula S, Zouiten O, Zoukar O, Zrafi W, Zribi A, and Zubia N
- Published
- 2018
Catalog
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.